PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer

NCT00005916 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

NIH

Sponsor class

Conditions

Prostate Cancer
Prostate Neoplasm

Interventions

DRUG: rV-PSA
DRUG: rF-PSA
DRUG: rV-B7.1

Sponsor

National Cancer Institute (NCI)